Literature DB >> 1677927

Recurrent mutation at aa 792 in the LDL receptor gene in a French patient.

N Loux1, P Benlian, D Pastier, C Boileau, J P Cambou, L Monnier, C Percheron, C Junien.   

Abstract

Many mutations in the low density lipoprotein receptor gene (LDLR) have been characterized at the molecular level in individuals with familial hypercholesterolemia. Most of the mutations that have been reported are large deletions or insertions in the gene, it being much more difficult to identify point mutations. In this study, 139 unrelated French familial hypercholesterolemia subjects were screened for the presence of three different previously described LDLR point mutations, employing the polymerase chain reaction and allele-specific oligonucleotide hybridization. Only one subject carried a point mutation at amino acid position 792, which substituted a Trp codon for a Stop codon. The same mutation has previously been described in a subject originating from Saudi Arabia. Haplotype analysis of LDLR associated with each mutation was performed. The haplotypes were totally different, suggesting that this mutation has occurred more than once.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677927     DOI: 10.1007/bf00200923

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

1.  Candidate gene approach to type IIa hypercholesterolaemia.

Authors:  P Benlian; C Bonaiti; P Douste-Blazy; C Junien
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

2.  The CpG dinucleotide and human genetic disease.

Authors:  D N Cooper; H Youssoufian
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

3.  Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior.

Authors:  O Attree; D Vidaud; M Vidaud; S Amselem; J M Lavergne; M Goossens
Journal:  Genomics       Date:  1989-04       Impact factor: 5.736

4.  Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.

Authors:  R K Saiki; T L Bugawan; G T Horn; K B Mullis; H A Erlich
Journal:  Nature       Date:  1986 Nov 13-19       Impact factor: 49.962

Review 5.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

6.  Polymorphic DNA haplotypes at the LDL receptor locus.

Authors:  E Leitersdorf; A Chakravarti; H H Hobbs
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

7.  The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2.

Authors:  I Henry; G Uzan; D Weil; H Nicolas; J C Kaplan; C Marguerie; A Kahn; C Junien
Journal:  Am J Hum Genet       Date:  1984-07       Impact factor: 11.025

8.  Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain.

Authors:  M A Lehrman; J L Goldstein; M S Brown; D W Russell; W J Schneider
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors.

Authors:  C G Davis; M A Lehrman; D W Russell; R G Anderson; M S Brown; J L Goldstein
Journal:  Cell       Date:  1986-04-11       Impact factor: 41.582

  10 in total
  4 in total

1.  Software and database for the analysis of mutations in the human LDL receptor gene.

Authors:  M Varret; J P Rabès; G Collod-Béroud; C Junien; C Boileau; C Béroud
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

2.  Two new polymorphisms in the coding sequence of the LDL receptor (LDLR) gene.

Authors:  B Saint-Jore; N Loux; C Junien; C Boileau
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

3.  Achondroplasia is defined by recurrent G380R mutations of FGFR3.

Authors:  G A Bellus; T W Hefferon; R I Ortiz de Luna; J T Hecht; W A Horton; M Machado; I Kaitila; I McIntosh; C A Francomano
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

4.  A very conservative region of ApoB-100 in the putative binding region to the LDL receptor in the Toulouse population.

Authors:  P Avoustin; H Mostachi; B Perret; J P Cambou; F Cambien; C de Préval
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.